Company China Regenerative Medicine International Limited
Equities
8158
KYG2129W1380
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.182 HKD | -4.21% | -32.59% | -66.91% |
Business Summary
Number of employees: 46
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Healthcare Products and Services
100.0
%
| 283 | 100.0 % | 232 | 100.0 % | -18.13% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
92.6
%
| 262 | 92.7 % | 214 | 92.6 % | -18.24% |
Hong Kong
7.4
%
| 21 | 7.3 % | 17 | 7.4 % | -16.70% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chuang Wang
CEO | Chief Executive Officer | 45 | 17/10/19 |
Po Tin Wong
DFI | Director of Finance/CFO | 47 | 31/08/22 |
Jinnan Zhang
CTO | Chief Tech/Sci/R&D Officer | 39 | 02/09/18 |
Wun Fat Khoo
IRC | Investor Relations Contact | 43 | 31/08/22 |
Yihu Sun
SAM | Sales & Marketing | - | - |
Yong Shan
PRN | Corporate Officer/Principal | 48 | 02/09/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Man Fai Leung
BRD | Director/Board Member | 66 | 29/12/21 |
Ho Yin Tsang
BRD | Director/Board Member | 38 | 29/01/20 |
Chuang Wang
CEO | Chief Executive Officer | 45 | 17/10/19 |
Chun Yu Huo
BRD | Director/Board Member | 50 | 29/01/20 |
Ming Liu
BRD | Director/Board Member | 67 | 29/12/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 304,252,480 | 112,739,173 ( 37.05 %) | 0 | 37.05 % |
Company contact information
China Regenerative Medicine International Ltd.
Suite 2310-2318 Miramar Tower, 132 Nathan Road
, Hong Kong
+
http://www.crmi.hkSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-66.91% | 7.09M | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.82B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.21% | 26.78B | |
+3.66% | 26.59B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- 8158 Stock
- Company China Regenerative Medicine International Limited